AIRS Medical inks partnership agreement with FONAR Corporation, leveraging the experience of the pioneering company in MRI... Success cases to be presented at RSNA 2023

(Neutral)

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

News Market Reaction – FONR

The recorded move for FONR in the trading session of this news was +0.94%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

11/06/2023 - 11:00 AM EST

SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- AIRS Medical, the leading AI-powered healthcare solution provider, recently announced a strategic partnership with FONAR Corporation (NASDAQ:FONR), the pioneer company in the MRI industry, to accelerate and develop business in North America.

AIRS Medical's product SwiftMR™ enhances the quality of MRI images through fine-tuned deep learning technology. SwiftMR™ can reduce MRI scan times by up to 50% while enhancing image quality using AI-powered denoising and sharpening. FONAR, founded in 1978, introduced the first commercial MRI scanner in 1980. Today its signature product is the 0.6T UPRIGHT^® MRI. The FONAR UPRIGHT^® acquires MR images in an open magnet that accommodates a wide variety of static and dynamic patient postures, including sitting; standing; upright flexion, extension, lateral bending, and rotation; as well as recumbent.

Through this partnership with FONAR, AIRS Medical has expanded the application of SwiftMR™ beyond 1.5T and 3.0T MRIs to include lower-field MRI scanners, securing access to an expanded market segment. Kevin Yang, Head of AIRS Medical's U.S. Operations & Clinical Research said, "AIRS Medical looks forward to the strategic partnership with FONAR. The combined efforts of both parties will accelerate our growth and strengthen our North American business capabilities. We expect that this agreement, leveraging FONAR's 45 years of expertise and capabilities, will bolster various aspects of our business operations in the U.S. market for SwiftMR™, including sales, marketing, and even research collaborations."

Under the slogan "Breaking the common belief of MRI through AI," AIRS Medical will showcase a range of cutting-edge AI healthcare technologies and advancements at RSNA 2023. A noteworthy development this year is clearance from the US FDA to expand the application of SwiftMR™ to all body parts, all pulse sequences, and all scanner models with 0.25T, 0.6T, 1.5T, and 3.0T.

In addition, AIRS Medical will showcase two accepted research abstracts and host two AI Theater Presentations. Yangsean Choi, MD, will discuss clinical applications and on-going research using SwiftMR™ in neuroradiology. John Greenhalgh, Ph.D., Vice President of Research and Development at FONAR Corporation, will share his experience successfully implementing SwiftMR™ in FONAR's UPRIGHT^® MRI systems. Both talks will be held at the RSNA AI Theater. Details can be found here. Please be sure to visit us at RSNA Booth #4552.

View original content:https://www.prnewswire.com/news-releases/airs-medical-inks-partnership-agreement-with-fonar-corporation-leveraging-the-experience-of-the-pioneering-company-in-mri-success-cases-to-be-presented-at-rsna-2023-301978321.html